Page last updated: 2024-12-05

diphenyldiselenide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diphenyldiselenide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15460
CHEMBL ID3122204
MeSH IDM0169570

Synonyms (37)

Synonym
c12h10se2
diselenide, diphenyl-
nsc49763
nsc-49763
phenyl diselenide
1666-13-3
diphenyl diselenide
bis(phenylselenide)
diselenide, diphenyl ,
diphenyldiselenide
nsc 49763
einecs 216-780-2
ccris 9227
inchi=1/c12h10se2/c1-3-7-11(8-4-1)13-14-12-9-5-2-6-10-12/h1-10
diphenyl diselenide, 98%
AC-11061
(phenyldiselanyl)benzene
D2186
A810750
diphenyldiselane
unii-9atu3z459q
9atu3z459q ,
BBL011512
AKOS005192800
STL146628
1,2-diphenyldiselane
CHEMBL3122204 ,
DTXSID6061864
1,2-diphenyldiselane #
J-200095
mfcd00003001
bdbm50028969
diphenyl diselenide, purum, >=97.0% (gc)
Q3538196
AMY31939
D90009
EN300-37568

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"It is well known that selenium is highly toxic to several species of mammals."( Investigations into the potential neurotoxicity induced by diselenides in mice and rats.
Curte, E; Meotti, FC; Nogueira, CW; Pilissão, C; Rocha, JB; Zeni, G, 2003
)
0.32
" Here we report the potential toxic effects of diphenyl diselenide (PhSe)(2), diphenyl ditelluride (PhTe)(2) and Ebselen in rats and mice."( Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and Ebselen for rats and mice.
Borges, VC; Meotti, FC; Nogueira, CW; Rocha, JB; Zeni, G, 2003
)
0.32
" Exposure of dams to (PhSe)(2) resulted in altered placental morphology that may have contributed to adverse reproductive outcomes."( Repeated administration of diphenyl diselenide to pregnant rats induces adverse effects on embryonic/fetal development.
Favero, AM; Manarin, FG; Nogueira, CW; Rocha, JB; Stangherlin, EC; Weis, SN; Zeni, G, 2007
)
0.34
" We recently showed the antioxidant effect of DPDS in V79 cells, and established the beneficial and toxic doses of this compound in this cell line."( Antioxidant activity of diphenyl diselenide prevents the genotoxicity of several mutagens in Chinese hamster V79 cells.
Moura, DJ; Pêgas Henriques, JA; Romano E Silva, AC; Rosa, RM; Saffi, J, 2007
)
0.34
" (PhSe)(2) was effective in attenuating these toxic effects caused by CPF exposure in rats."( Diphenyl diselenide attenuates hepatic and hematologic toxicity induced by chlorpyrifos acute exposure in rats.
Acker, CI; Dos Santos, MP; Mazzanti, CM; Nogueira, CW; Souza, AC, 2012
)
0.38
" Our group has previously demonstrated that the oral and repeated administration (21 days) of MeHg (40 mg/L) induced MeHg brain accumulation at toxic concentrations, and a pattern of severe cortical and cerebellar biochemical and behavioral."( Protective effects of diphenyl diselenide in a mouse model of brain toxicity.
da Rocha, JB; Dafré, AL; de Bem, AF; Farina, M; Feksa, L; Glaser, V; Latini, A; Moritz, B; Nazari, EM; Rauh Müller, YM; Schmitz, A; Straliottoa, MR, 2013
)
0.39
" These results show that (PhSe)2 can be efficient in protecting against these toxic effects presented by this Hg exposure model."( Effectiveness of (PhSe)2 in protect against the HgCl2 toxicity.
da Costa, M; Fiuza, Tda L; Oliveira, CS; Oliveira, VA; Pereira, ME; Zeni, G, 2015
)
0.42
" Mercury is a toxic metal, widespread in the environment."( Chemical Speciation of Selenium and Mercury as Determinant of Their Neurotoxicity.
Aschner, M; Oliveira, CS; Piccoli, BC; Rocha, JBT, 2017
)
0.46

Compound-Compound Interactions

ExcerptReferenceRelevance
"Herein, we describe the in vitro activity of a combination of the organoselenium compounds diphenyl diselenide and ebselen alone and in combination with amphotericin B, caspofungin, itraconazole, and voriconazole against 25 clinical isolates of Fusarium spp."( Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp.
Alves, SH; Azevedo, MI; Chassot, F; Keller, JT; Loreto, ÉS; Santurio, JM; Venturini, TP; Zeni, G, 2016
)
0.43
" Given the scarcity of options for sporotrichosis treatment and the promising activity of diphenyl diselenide (PhSe)2 against a diversity of fungal pathogens, this study aimed to evaluate the in vitro susceptibility of Sporothrix brasiliensis to (PhSe)2 alone and in combination with itraconazole (ITC)."( Antifungal activity of diphenyl diselenide alone and in combination with itraconazole against Sporothrix brasiliensis.
Klafke, GB; Mattei, AS; Mendes, JF; Poester, VR; Ramis, IB; Sanchotene, KO; Xavier, MO, 2019
)
0.51
"This study evaluated the in vitro susceptibility of Trichosporon asahii strains to diphenyl diselenide (DPDS) and ebselen (EBS) alone and in combination with amphotericin B (AMB), fluconazole (FCZ), itraconazole (ITZ) and caspofungin (CAS) using the microdilution method."( In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii.
Bedin Denardi, L; Felli Kubiça, T; Hartz Alves, S; Morais Santurio, J; Oliveira, V; Silva de Loreto, É; Weiblen, C; Zeni, G, 2019
)
0.51
" This study contributes with data of DD alone and in combination with classical drugs of choice for cryptococcosis treatment."( In vitro anti-Cryptococcus activity of diphenyl diselenide alone and in combination with amphotericin B and fluconazole.
Benelli, JL; Klafke, GB; Munhoz, LS; Poester, VR; Stevens, DA; Xavier, MO, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" These data contribute to the knowledge of the toxicokinetic properties of (PhSe)₂ and further explain its low bioavailability in experimental models."( Physicochemical and biochemical profiling of diphenyl diselenide.
Bronze, MR; Constantino, L; Nogueira, CW; Prigol, M; Zeni, G, 2013
)
0.39
" However, the poor water-solubility and its low oral bioavailability may be considered an obstruction for the clinical utility of this compound."( Diphenyl diselenide-loaded nanocapsules: preparation and biological distribution.
Alves, MP; de Souza, D; Dornelles, L; Giordani, CF; Nogueira, CW; Prigol, M; Rodrigues, OE, 2014
)
0.4
" In addition, studies have shown that DPDS-loaded nanocapsules (DPDS-NCS) have greater bioavailability than free DPDS in mice."( Free radical scavenging in vitro and biological activity of diphenyl diselenide-loaded nanocapsules: DPDS-NCS antioxidant and toxicological effects.
Amaral, GP; Barcelos, RP; de Carvalho, NR; Dobrachinski, F; Giordani, CF; Oliveira, CS; Oliveira, VA; Pereira, ME; Rodrigues, OE; Soares, FA; Stefanello, ST, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" To this end, male Wistar rats received (PhSe)2 by oral route at the dosage of 31."( Oral administration of diphenyl diselenide potentiates hepatotoxicity induced by carbon tetrachloride in rats.
Borges, LP; Nogueira, CW; Souza, AC, 2009
)
0.35
" Fish were fed for 74 days with a diet containing 3 mg/Kg DD, a concentration chosen after experiments based in a dose-response curve (DD 1, 2 and 3 mg/Kg) that did not cause overt toxicity (mortality, weight loss and neurobehavioral deficits)."( Hyperglycemia elicits anxiety-like behaviors in zebrafish: Protective role of dietary diphenyl diselenide.
Barbosa, NV; de Macedo, GT; Dos Santos, MM; Heidrich, GM; Loro, VL; Picoloto, RS; Prestes, AS; Rosemberg, DB, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-butyrobetaine dioxygenaseHomo sapiens (human)IC50 (µMol)46.40000.69003.16457.9000AID1166880; AID1166881; AID1166882; AID1166883; AID1166884
Histone-lysine N-methyltransferase EHMT2Homo sapiens (human)IC50 (µMol)0.55000.00251.14809.2000AID1374899
Histone-lysine N-methyltransferase EHMT1Homo sapiens (human)IC50 (µMol)0.86000.01300.79954.9000AID1374900
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-butyrobetaine dioxygenaseHomo sapiens (human)Kd200.00003.60005.26677.6000AID1166891; AID1166892
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (27)

Processvia Protein(s)Taxonomy
carnitine biosynthetic processGamma-butyrobetaine dioxygenaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to starvationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
regulation of DNA replicationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
DNA methylation-dependent heterochromatin formationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
synaptonemal complex assemblyHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
spermatid developmentHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
long-term memoryHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
fertilizationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
peptidyl-lysine dimethylationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
regulation of protein modification processHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
organ growthHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
phenotypic switchingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of gene expression via chromosomal CpG island methylationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
response to ethanolHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
behavioral response to cocaineHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
oocyte developmentHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
neuron fate specificationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
response to fungicideHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to cocaineHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to xenobiotic stimulusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of autophagosome assemblyHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
DNA methylation-dependent heterochromatin formationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
peptidyl-lysine monomethylationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
peptidyl-lysine dimethylationHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
regulation of embryonic developmentHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
response to fungicideHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
positive regulation of cold-induced thermogenesisHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
iron ion bindingGamma-butyrobetaine dioxygenaseHomo sapiens (human)
protein bindingGamma-butyrobetaine dioxygenaseHomo sapiens (human)
zinc ion bindingGamma-butyrobetaine dioxygenaseHomo sapiens (human)
gamma-butyrobetaine dioxygenase activityGamma-butyrobetaine dioxygenaseHomo sapiens (human)
identical protein bindingGamma-butyrobetaine dioxygenaseHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
transcription corepressor bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
p53 bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
enzyme bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K27 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
C2H2 zinc finger domain bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K56 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K9me2 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
promoter-specific chromatin bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
transcription corepressor bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
p53 bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
histone H3K27 methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
C2H2 zinc finger domain bindingHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
histone H3K9me2 methyltransferase activityHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
cytosolGamma-butyrobetaine dioxygenaseHomo sapiens (human)
extracellular exosomeGamma-butyrobetaine dioxygenaseHomo sapiens (human)
mitochondrionGamma-butyrobetaine dioxygenaseHomo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nuclear speckHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
nuclear bodyHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID1683015Glutathione peroxidase-like catalytic antioxidant activity in pH 7 phosphate buffer assessed as catalytic reduction of H2O2 by measuring initial velocity at 0.2 mM and 25 degreeC using reduced DTT as di-thiol co-substrate in presence of NADPH by UV absorb
AID1330657Glutathione peroxidase like activity assessed as hydrogen peroxide reduction by measuring reaction rate at 0.1 mM measured for 180 sec in presence of PhSH relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123Selenoureido-iminosugars: A new family of multitarget drugs.
AID1166887Binding affinity to human BBOX assessed as quenching of intrinsic tryptophan fluorescence at 50 to 200 uM in absence of Fe(II)2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1659542Antioxidant activity assessed as inhibition of Fe(II)-induced lipid peroxidation at 200 uM after 30 mins by TBARS assay2020Bioorganic & medicinal chemistry, 05-01, Volume: 28, Issue:9
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
AID1683016Glutathione peroxidase-like catalytic anti-lipid peroxidation activity assessed as inhibition of AAPH-induced lipid peroxidation incubated for 3 hrs using soybean lecithin/cholesterol-liposomes by TBARS assay
AID1322221Antioxidant activity assessed as inhibition of Fe2+-induced thiobarbituric acid reactive substance formation in phospholipids extracted from egg yolk by measuring malondialdehyde levels per mg of triglycerides at 100 uM after 1 hr by UV-Vis spectrophotome2016Bioorganic & medicinal chemistry, 11-15, Volume: 24, Issue:22
Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease.
AID1378382GPx-like activity of the compound assessed as half life for H2O2 reduction by measuring oxidation of PhSH to (PhS)2 at 50 uM measured for 180 secs by spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
AID1374902Inhibition of wild type recombinant human histone lysine methyltransferase GLP (951 to 1235 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS assessed as zinc ions ejection from Cys4-Zn finger at 100 uM by FluoZin-3 based fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1374901Inhibition of wild type recombinant human histone lysine methyltransferase G9a (913 to 1193 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS assessed as zinc ions ejection from Cys4-Zn finger at 100 uM by FluoZin-3 based fluorescence assay2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1378379GPx-like activity of the compound assessed as velocity for H2O2 reduction by measuring oxidation of PhSH to (PhS)2 at 50 uM measured for 180 secs by spectrophotometric analysis2017European journal of medicinal chemistry, Sep-29, Volume: 138New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
AID1659539Antioxidant activity assessed as GPx-like activity to decompose hydrogen peroxide at 450 uM measured for 20 mins by spectrophotometer method2020Bioorganic & medicinal chemistry, 05-01, Volume: 28, Issue:9
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
AID1330673Glutathione peroxidase like activity assessed as hydrogen peroxide reduction by measuring compound Km measured for 180 sec in prescence of varying levels of Phsh by Hanes-Woof plot method2016European journal of medicinal chemistry, Nov-10, Volume: 123Selenoureido-iminosugars: A new family of multitarget drugs.
AID1683014Glutathione peroxidase-like catalytic antioxidant activity in pH 7 phosphate buffer assessed as catalytic reduction of H2O2 by measuring initial velocity at 100 uM and 25 degreeC using GSH as mono-thiol co-substrate in presence of NADPH by UV absorbance a
AID1374896Inhibition of wild type recombinant human histone lysine methyltransferase G9a (913 to 1193 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS at 100 uM using ARTKQTARKSTGGKA as substrate preincubated for 5 mins followed by substrate/SAM addit2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1166884Inhibition of human BBOX pre-incubated for 25 mins using TBS-protected fluorescein probe and Fe (II) (Fe(NH4)2(SO4)2 salt by fluoride release assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1330674Glutathione peroxidase like activity assessed as hydrogen peroxide reduction by measuring compound Vmax measured for 180 sec in prescence of varying levels of Phsh by Hanes-Woof plot method2016European journal of medicinal chemistry, Nov-10, Volume: 123Selenoureido-iminosugars: A new family of multitarget drugs.
AID1166885Induction of Zn(II) from human BBOX assessed as zinc release by fluorescence based assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1166881Inhibition of human BBOX pre-incubated for 10 mins using TBS-protected fluorescein probe and Fe (II) (Fe(NH4)2(SO4)2 salt by fluoride release assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1180950Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
An investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides.
AID1506745Antioxidant activity assessed as inhibition of Fe2+-induced phosphatidylcholine oxidation incubated for 1 hr by TBARS assay2017MedChemComm, Feb-01, Volume: 8, Issue:2
Synthesis, antioxidant and antitumoral activities of 5'-arylchalcogeno-3-aminothymidine (ACAT) derivatives.
AID1374897Inhibition of wild type recombinant human histone lysine methyltransferase GLP (951 to 1235 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS at 10 uM using ARTKQTARKSTGGKA as substrate preincubated for 5 mins followed by substrate/SAM additi2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1659541Antioxidant activity assessed as half life of DPPH radical scavenging activity at 500 uM for 180 mins measured every 30 mins relative to control2020Bioorganic & medicinal chemistry, 05-01, Volume: 28, Issue:9
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
AID1180953Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
An investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides.
AID1165407Antioxidant activity assessed as glutathione peroxidase-like activity by UV spectrophotometry relative to ebselen2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis and biological evaluation of new nitrogen-containing diselenides.
AID1330672Glutathione peroxidase like activity assessed as hydrogen peroxide reduction by measuring reaction half life at 0.1 mM measured for 180 sec in presence of PhSH (Rvb = 351.9 mins)2016European journal of medicinal chemistry, Nov-10, Volume: 123Selenoureido-iminosugars: A new family of multitarget drugs.
AID1165406Antioxidant activity assessed as glutathione peroxidase-like activity assessed as time required to reduce the thiol concentration by 50% after addition of H2O2 by UV spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis and biological evaluation of new nitrogen-containing diselenides.
AID1659538Antioxidant activity assessed as half life of GPx-like activity to decompose hydrogen peroxide at 450 uM measured for 20 mins by spectrophotometer method2020Bioorganic & medicinal chemistry, 05-01, Volume: 28, Issue:9
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
AID1374899Inhibition of wild type recombinant human histone lysine methyltransferase G9a (913 to 1193 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS using ARTKQTARKSTGGKA as substrate preincubated for 5 mins followed by substrate/SAM addition measur2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1330676Glutathione peroxidase like activity assessed as hydrogen peroxide reduction by measuring Kcat to Kuncat ratio measured for 180 sec in prescence of varying levels of Phsh by Hanes-Woof plot method2016European journal of medicinal chemistry, Nov-10, Volume: 123Selenoureido-iminosugars: A new family of multitarget drugs.
AID1330675Glutathione peroxidase like activity assessed as hydrogen peroxide reduction by measuring compound Kcat measured for 180 sec in prescence of varying levels of Phsh by Hanes-Woof plot method2016European journal of medicinal chemistry, Nov-10, Volume: 123Selenoureido-iminosugars: A new family of multitarget drugs.
AID1166883Inhibition of human BBOX pre-incubated for 20 mins using TBS-protected fluorescein probe and Fe (II) (Fe(NH4)2(SO4)2 salt by fluoride release assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1506755Thiol peroxidase-like activity assessed as induction of hydrogen peroxide decomposition at 50 to 250 uM using benzenethiol incubated for 20 mins2017MedChemComm, Feb-01, Volume: 8, Issue:2
Synthesis, antioxidant and antitumoral activities of 5'-arylchalcogeno-3-aminothymidine (ACAT) derivatives.
AID1166880Inhibition of human BBOX pre-incubated for 1 min using TBS-protected fluorescein probe and Fe (II) (Fe(NH4)2(SO4)2 salt by fluoride release assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1378380GPx-like activity of the compound assessed as H2O2 reduction by measuring oxidation of PhSH to (PhS)2 at 50 uM measured for 180 secs by spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
AID1374895Inhibition of wild type recombinant human histone lysine methyltransferase G9a (913 to 1193 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS at 10 uM using ARTKQTARKSTGGKA as substrate preincubated for 5 mins followed by substrate/SAM additi2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1180952Cytotoxicity against human 786-O cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
An investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides.
AID1180951Cytotoxicity against human OVCAR5 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
An investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides.
AID1166892Binding affinity to human BBOX in presence of Fe(II) by tryptophan fluorescence quenching binding assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1180954Cytotoxicity against human PC3 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
An investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides.
AID1659540Antioxidant activity assessed as inhibition of Fe(II)-induced lipid peroxidation after 30 mins by TBARS assay2020Bioorganic & medicinal chemistry, 05-01, Volume: 28, Issue:9
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
AID1374898Inhibition of wild type recombinant human histone lysine methyltransferase GLP (951 to 1235 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS at 100 uM using ARTKQTARKSTGGKA as substrate preincubated for 5 mins followed by substrate/SAM addit2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1374900Inhibition of wild type recombinant human histone lysine methyltransferase GLP (951 to 1235 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS using ARTKQTARKSTGGKA as substrate preincubated for 5 mins followed by substrate/SAM addition measur2018Bioorganic & medicinal chemistry letters, 04-15, Volume: 28, Issue:7
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
AID1166882Inhibition of human BBOX pre-incubated for 15 mins using TBS-protected fluorescein probe and Fe (II) (Fe(NH4)2(SO4)2 salt by fluoride release assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1166891Binding affinity to human BBOX by tryptophan fluorescence quenching binding assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Ejection of structural zinc leads to inhibition of γ-butyrobetaine hydroxylase.
AID1071367Antioxidant activity assessed as hydrogen peroxide radical scavenging activity by measuring ratio of initial rate of catalyzed reaction to spontaneous reaction at 100 uM measured every 30 secs for 10 mins by GPx-like catalytic activity assay2014European journal of medicinal chemistry, Feb-12, Volume: 73Synthesis and antiproliferative activity of novel selenoester derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (271)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.37)18.7374
1990's1 (0.37)18.2507
2000's101 (37.27)29.6817
2010's145 (53.51)24.3611
2020's23 (8.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.03 (24.57)
Research Supply Index5.63 (2.92)
Research Growth Index6.88 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.36%)5.53%
Reviews3 (1.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other272 (98.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]